Exousia Bio (LMMY) Gross Profit (2023 - 2025)

Exousia Bio has disclosed Gross Profit across 3 years of filings, most recently posting -$62108.0 for Q4 2025.

• Gross Profit for Q4 2025 came in at -$62108.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was -$69359.0 (down 4160.83% YoY), and the FY2025 annual result was -$3501.0, down 291.0% from the prior year.
• Gross Profit came in at -$62108.0 for Q4 2025 at Exousia Bio, down from -$7251.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $3875.0 in Q4 2023 to a low of -$62108.0 in Q4 2025.
• The 3-year median for Gross Profit is -$1083.5 (2024), against an average of -$10629.3.
• Peak annual rise in Gross Profit reached 22.55% in 2025, while the deepest fall reached 22.55% in 2025.
• Exousia Bio's Gross Profit stood at $3875.0 in 2023, then decreased by 3.23% to $3750.0 in 2024, then slumped by 1756.21% to -$62108.0 in 2025.
• The last three Gross Profit figures came in at -$62108.0 (Q4 2025), -$7251.0 (Q2 2025), and $3750.0 (Q3 2024), per Business Quant data.